Since early CRP changes correlate with the adequacy of antibiotic therapy [19,24-26] and to the bacterial load, at least in VAP patients [24], it seems that the CRP course could be used as a surrogate marker of the clinical course of infection [11]. The gene discussed is CRP; the disease is ventilator-associated pneumonia.